Archives of Virology

, Volume 134, Issue 1, pp 61–71

Development of specific antibody patterns and clinical symptoms following Ockelbo virus infection

  • Sirkka Vene
  • Christer Franzén
  • Bo Niklasson
Original Papers

DOI: 10.1007/BF01379107

Cite this article as:
Vene, S., Franzén, C. & Niklasson, B. Archives of Virology (1994) 134: 61. doi:10.1007/BF01379107


Sixteen patients with symptoms typical for Ockelbo disease (rash, arthralgia, fever) were enrolled in a 2 1/2 year study, during which clinical symptoms were recorded and ELISA was employed to study specific IgM, IgG and IgG subclass development. Initially, all patients presented with rash and arthralgia, and five patients still suffered from joint symptoms at the end of the study period. Ockelbo virus specific IgM was detected during the first week post onset in 6 patients and in 15 patients by day 14. One patient failed to develop specific IgM and was later diagnosed with a human parvovirus B 19 infection. All patients were IgM-negative 2 1/2 years post onset. Seroconversions or significant titer rises for specific total IgG were seen in 15 patients. IgG titers generally peaked within one year but in two patients maximum titers were seen 2 1/2 years post onset. Development of IgG1 followed that of total IgG, while IgG3, after an initial increase in all Ockelbo disease patients, remained at peak levels for one year in four patients, three of whom still had detectable IgG3 at the end of the study period. Ockelbo virus specific IgG2 or IgG4 was not detected in any of the patients.

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • Sirkka Vene
    • 1
  • Christer Franzén
    • 2
  • Bo Niklasson
    • 3
    • 4
  1. 1.Department of VirologySwedish Institute for Infectious Disease ControlStockholm
  2. 2.Department of Infectious DiseasesSundsvall County HospitalSundsvall
  3. 3.Department of VirologyKarolinska Institute, Swedish Institute for Infectious Disease ControlStockholm
  4. 4.National Defense Research Establishment, FOA-4UmeåSweden
  5. 5.Department of Infectious Diseases, KärnsjukhusetSkövdeSweden